These findings suggest that FOXO1 is a signaling molecule upstream of HIF-1α in the angiogenic pathway in gastric cancer, and that gastric tumor angiogenesis could be inhibited, at least in part, by FOXO1 activation. This evidence concerns the gene FOXO1 and gastric cancer.